Prosecution Insights
Last updated: April 19, 2026

Examiner: LIN, JERRY

Tech Center 1600 • Art Units: 1631 1671 1685

This examiner grants 72% of resolved cases

Performance Statistics

72.1%
Allow Rate
+12.1% vs TC avg
845
Total Applications
+15.4%
Interview Lift
1461
Avg Prosecution Days
Based on 827 resolved cases, 2023–2026

Rejection Statute Breakdown

33.2%
§101 Eligibility
14.4%
§102 Novelty
21.0%
§103 Obviousness
19.0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19256936 PREDICTIVE MODEL FOR DETERMINING CHANGES IN MOLECULAR STATE Non-Final OA Guardant Health, Inc.
19287260 MULTIPLE-TIERED SCREENING AND DIAGNOSTIC ANALYSIS Non-Final OA Flagship Pioneering Innovations VI, LLC
19045446 MULTIPLE-TIERED SCREENING AND SECOND ANALYSIS Non-Final OA Flagship Pioneering Innovations VI, LLC
17767615 Detecting Homologous Recombination Deficiencies (HRD) in Clinical Samples Non-Final OA ImmunityBio, Inc.
19183603 MOLECULAR PROFILING OF TUMORS Non-Final OA Caris MPI, Inc.
16664216 CANCER BIOMARKERS Non-Final OA MYRIAD GENETICS, INC.
18050645 CELL-FREE DNA METHYLATION PATTERNS FOR DISEASE AND CONDITION ANALYSIS Non-Final OA University of Southern California
16114725 Mechanistic Predictive Model Of Pharmacokinetic Profile Of Oral Compounds In Fasted And Fed State Final Rejection Northeastern University
17932712 SYSTEMS AND METHODS FOR IDENTIFYING SOMATIC MUTATIONS Non-Final OA LIFE TECHNOLOGIES CORPORATION
17690958 DETECTING AND QUANTIFYING A LIQUID AND/OR FOOD INTAKE OF A USER WEARING A HEARING DEVICE Non-Final OA SONOVA AG
18517619 QUICK METHOD FOR ACCURATELY ESTIMATING AVERAGE ELECTRON DENSITIES Non-Final OA UNITED ARAB EMIRATES UNIVERSITY
17596328 USER TERMINAL AND METHOD FOR MANAGING STATUS THROUGH USER TERMINAL AFTER AUTOMATICALLY INJECTING MEDICATION Non-Final OA EOFLOW CO., LTD.
18171109 SYSTEMS AND METHODS FOR FORMULATING RUMINANT DIETS Final Rejection Boveta Nutrition LLC
16937287 METHODS AND SYSTEMS FOR ABNORMALITY DETECTION IN THE PATTERNS OF NUCLEIC ACIDS Final Rejection Freenome Holdings, Inc.
17718409 Method For Detecting The Presence Of Abnormal Tissue Non-Final OA SOFTSYSTEM SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (PL)
17245440 METHODS AND SYSTEMS FOR EVALUATION OF RISK OF SUBSTANCE USE DISORDERS Non-Final OA Prescient Medicine Holdings, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month